Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Hits Price Target Forecast with 22.08% Profit - QuantWave's Success

August 08, 2023
The stock of ELI LILLY AND COMPANY has successfully reached the price target forecast set by QuantWave, resulting in a profit of 22.08%. The forecast signal was generated on May 9, 2023, with the price at 421.22 $ and the predicted direction being long. On August 8, 2023, the stock reached the target price of 514.21 $, confirming the accuracy of the forecast.


This achievement highlights the effectiveness of QuantWave's analytics in providing insightful and precise predictions for investors. Market analysis indicates that several factors contributed to ELI LILLY AND COMPANY's stock movement, including positive developments in the company's product pipeline, strong financial performance, and overall industry trends.


QuantWave continues to be a reliable automated forecasting platform where users can access forecasts for a variety of stocks, presenting potential profit opportunities. For those interested in delving deeper into investment strategies, QuantSchool offers a comprehensive professional framework to leverage the QuantWave forecasting system effectively, guiding investors on generating consistent income.


Overall, the successful attainment of the price target forecast for ELI LILLY AND COMPANY underlines the accuracy and value of QuantWave's predictive analytics in today's dynamic market environment.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

FCXApril 4, 2025QuantWave Achieves 21.09% Profit Target Forecast for Freeport-McMoran Inc.  ~1 min.

QuantWave, the automated forecasting platform, has successfully reached a price target forecast for Freeport-McMoran Inc., resulting in a profit of 21.09%....

CVXOctober 27, 2023QuantWave Achieves 5.08% Profit Target Forecast for Chevron Corporation  ~1 min.

QuantWave, the automated forecasting platform, has successfully hit its price target forecast for Chevron Corporation's stock....

TSLADecember 5, 2024QuantWave Hits Target Forecast for Tesla, Inc with 57.76% Profit  ~1 min.

QuantWave, an automated forecasting platform, successfully achieved its price target forecast for the stock of TESLA, INC. The forecast signal date was November 22, 2023, with a price of $234....

MOSJune 23, 2022THE MOSAIC COMPANY Stock Hits Price Target Forecast with 14.2% Profit  ~1 min.

QuantWave, a leading automated forecasting platform, successfully predicted the short direction for THE MOSAIC COMPANY stock on June 14, 2022, when the price was at 48.86 $....

TDSOctober 18, 2024TELEPHONE AND DATA SYSTEMS, INC. Hits Price Target Forecast with 32.48% Profit  ~1 min.

On July 16, 2024, QuantWave issued a forecast signal for TELEPHONE AND DATA SYSTEMS, INC. with a predicted direction of long and a price of 21.93 $....